Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 9/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31306389 | 0.89 | TDP1 (0.47) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL31306390 | 0.89 | TDP1 (0.47) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL1806887 | 0.89 | TDP1 (0.47) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL1816745 | 0.80 | ERN1 (0.43) | ERN1CES2CES1TDP1MEN1 | |
| SCHEMBL659120 | 0.80 | ERN1 (0.43) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL24525370 | 0.78 | ERN1 (0.42) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL2263615 | 0.78 | ERN1 (0.63) | ERN1TDP1 | |
| SCHEMBL584614 | 0.78 | ERN1 (0.42) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL13929083 | 0.78 | ERN1 (0.42) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL7762075 | 0.78 | TDP1 (0.45) | ERN1TDP1MEN1LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 866 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118103371-B | EGFR inhibitor and preparation method and application thereof | SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-119798970-A | High-temperature-resistant power tube and production process thereof | 赣州祺琳新材料有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-118895668-A | High-waterproofness fabric | 南通东润智能科技有限公司 | 2024-11-05 | — | — | CN | claimed |
| CN-114409556-B | Preparation method of 3, 4-disubstituted-2-aminobenzaldehyde | 兰州康鹏威耳化工有限公司 | 2024-10-18 | — | — | CN | claimed |
| CN-118459420-A | Thiazolinone compound containing multiple halogen atoms and preparation method thereof | 南京工业大学 | 2024-08-09 | — | — | CN | claimed |
| CN-118459422-A | Thiazole thiazolinone compound containing multiple halogen atoms and preparation method thereof | 南京工业大学 | 2024-08-09 | — | — | CN | claimed |
| CN-115611717-B | Preparation method of polyfluorobenzaldehyde | 上海万溯药业有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118103371-A | EGFR inhibitor and preparation method and application thereof | 山东新时代药业有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-115745766-B | Preparation method of trifluorobenzaldehyde and trifluorobenzyl bromide | 兰州康鹏威耳化工有限公司 | 2024-05-14 | — | — | CN | claimed |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION | 2024-02-01 | — | — | US | claimed |
| US-9422299-B2 | Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | EUROSCREEN SA (BE) | 2016-08-23 | — | — | US | claimed |
| CN-104151150-A | Preparation method of 3,4-di(3,4,5-trifluorophenyl)-2,5-diphenylcyclopentyldienone | UNIV SHANDONG | 2014-11-19 | — | — | CN | claimed |
| CN-102617647-A | Terpyridyl ruthenium coordination compound, and preparation method and application thereof | UNIV SUN YAT SEN | 2012-08-01 | — | — | CN | claimed |
| CN-101754960-A | tetrahydropyranochromene gamma-secretase inhibitors | SCHERING CORP | 2010-06-23 | — | — | CN | claimed |
| US-20060084176-A1 | Detection of uronium salts | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-04-20 | — | — | US | claimed |
| US-20050239853-A1 | New compounds | BIOVITRUM AB (SE) | 2005-10-27 | — | — | US | claimed |
| WO-2005075471-A2 | THIAZOL-COMPOUNDS AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS | BIOVITRUM AB (SE) | 2005-08-18 | — | — | WO | claimed |
| US-20020146633-A1 | FLUORINATED AROMATIC ACETAL POLYMERS AND PHOTOSENSITIVE COMPOSITIONS CONTAINING SUCH POLYMERS | KODAK POLYCHROME GRAPHICS L.L.C. | 2002-10-10 | — | — | US | claimed |
| US-6458503-B1 | BLEND WITH DIAZO RESIN; LITHOGRAPHIC PRINTING PLATES; PHOTOPOLYMERIZATION AND CROSSLINKING | KODAK POLYCHROME GRAPHICS LLC | 2002-10-01 | — | — | US | claimed |
| WO-2002073315-A1 | FLUORINATED AROMATIC ACETAL POLYMERS AND PHOTOSENSITIVE COMPOSITIONS CONTAINING SUCH POLYMERS | KODAK POLYCHROME GRAPHICS COMPANY, LTD. (US) | 2002-09-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239853-A1 | New compounds | HSD11B1, CYP11B1, HSD3B1 | ERN1 1308/4885CES2 183/4885CES1 28/4885 |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | CHP1, NFATC1, PPP3R1 | ERN1 1903/4885CES2 2886/4885CES1 3249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.